Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Riley

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Plos Medicine|January 25, 2008
Multi-host transmission dynamics of Schistosoma japonicum in Samar province, the PhilippinesSteven Riley, Hélène Carabin, Patrick Bélisle, et al.
American Journal of Public Health|September 21, 2023
Design and Implementation of a National Program to Monitor the Prevalence of SARS-CoV-2 IgG Antibodies in England Using Self-Testing: The REACT-2 StudyHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Nature Medicine|February 16, 2021
Time to evaluate COVID-19 contact-tracing appsVittoria Colizza, Eva Grill, Rafael Mikolajczyk, et al.
Proceedings. Biological Sciences|July 11, 2014
Social contacts and the locations in which they occur as risk factors for influenza infectionKin O Kwok, Benjamin J Cowling, Vivian W I Wei, et al.
Plos One|September 11, 2009
Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in MexicoMarc Lipsitch, Martin Lajous, Justin J O'Hagan, et al.
Plos Computational Biology|October 31, 2017
A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreakMax S Y Lau, Gavin J Gibson, Hola Adrakey, et al.
European Journal of Heart Failure|October 18, 2020
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension studyThibaud Damy, Pablo Garcia-Pavia, Mazen Hanna, et al.
Science (New York, N.Y.)|June 23, 2012
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis"Maria D Van Kerkhove, Steven Riley, Marc Lipsitch, et al.
Royal Society Open Science|August 12, 2022
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling studyMichael J Tildesley, Anna Vassall, Steven Riley, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life courseJames A Hay, Huachen Zhu, Chao Qiang Jiang, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Plos Medicine|January 25, 2008
Multi-host transmission dynamics of Schistosoma japonicum in Samar province, the PhilippinesSteven Riley, Hélène Carabin, Patrick Bélisle, et al.
American Journal of Public Health|September 21, 2023
Design and Implementation of a National Program to Monitor the Prevalence of SARS-CoV-2 IgG Antibodies in England Using Self-Testing: The REACT-2 StudyHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Nature Medicine|February 16, 2021
Time to evaluate COVID-19 contact-tracing appsVittoria Colizza, Eva Grill, Rafael Mikolajczyk, et al.
Proceedings. Biological Sciences|July 11, 2014
Social contacts and the locations in which they occur as risk factors for influenza infectionKin O Kwok, Benjamin J Cowling, Vivian W I Wei, et al.
Plos One|September 11, 2009
Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in MexicoMarc Lipsitch, Martin Lajous, Justin J O'Hagan, et al.
Plos Computational Biology|October 31, 2017
A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreakMax S Y Lau, Gavin J Gibson, Hola Adrakey, et al.
European Journal of Heart Failure|October 18, 2020
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension studyThibaud Damy, Pablo Garcia-Pavia, Mazen Hanna, et al.
Science (New York, N.Y.)|June 23, 2012
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis"Maria D Van Kerkhove, Steven Riley, Marc Lipsitch, et al.
Royal Society Open Science|August 12, 2022
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling studyMichael J Tildesley, Anna Vassall, Steven Riley, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life courseJames A Hay, Huachen Zhu, Chao Qiang Jiang, et al.
Pageof 21